EichorEICHOR
Location: Jerusalem Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Jerusalem

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Shaare Zedek Medical Center ( Site 0075) · Merck Sharp & Dohme LLC · NCT04165070Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Shaare Zedek Medical Center · Pfizer · NCT07028853A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Hadassah Medical Center-Hemato-Oncology ( Site 1500) · Merck Sharp & Dohme LLC · NCT06136559Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Hadassah Medical Center · Bristol-Myers Squibb · NCT07106762Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Shaare Zedek Medical Center ( Site 1706) · Merck Sharp & Dohme LLC · NCT06393374This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Shaare Zedek Medical Center · Pfizer · NCT06758401A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0168 · Bristol-Myers Squibb · NCT06929273Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · AGO Study Group · NCT05009082A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · Hadassah Medical Center · Pfizer · NCT07206225Testing the Cog-Fun Aging Program for Older Adults With Subjective Cognitive Decline
NA · Hebrew University of Jerusalem · Hebrew University of Jerusalem · NCT06816797A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Shaare Zedek Medical Center · Eli Lilly and Company · NCT07483099LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Clalit Health Services - Lev Talpiot Clinic · Eli Lilly and Company · NCT07415044A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Shaare Zedek Medical Center ( Site 1905) · Merck Sharp & Dohme LLC · NCT07216703A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pou
Phase 3 · Shaare Zedek Medical Center · Takeda · NCT06443502A Single Arm, Prospective, Open Label, Multi Center, Phase Ib Study to Evaluate the Safety, Tolerability and Initial Eff
Phase 1 · Hadassah Medical Center · IntraGel Therapeutics · NCT05200650Determinants of Warfarin Metabolism
NA · Hadassah Medical Organization · Hadassah Medical Organization · NCT00162474Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Shaare Zedek Medical Center · Eli Lilly and Company · NCT06890598A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Shaare Zedek Medical Center · Bayer · NCT07192952Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · Shaare Zedek Medical Center · University of California, San Francisco · NCT05009992A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Hadassah Medical Center · Eli Lilly and Company · NCT07222332A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Hadassah Medical Center · Regeneron Pharmaceuticals · NCT06091865Risankizumab in Children With Crohn's Disease (RisaKids)
NA · Shaare Zedek Medical Center · Shaare Zedek Medical Center · NCT06298188Pilot Study on a Health Promotion Intervention for Ultra-Orthodox Mothers of Children With ADHD
NA · Hebrew University · Adina Maeir · NCT06703242A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Shaare Zedek Medical Center · Pfizer · NCT07144280A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Phase 2 · Shaare Zedek Medical Center · Pfizer · NCT07470879Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Shaare Zedek Medical Center · Eli Lilly and Company · NCT06937086A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Hadassah Medical Center · Loxo Oncology, Inc. · NCT05254743
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.